- Fee assured
- Verified this account
- Benign Prostate disorders
- General urology
- Urological oncology
Prof Madaan manages most general urological conditions and is the lead clinician for the treatment of urological cancer at Darent Valley Hospital (DVH), Dartford. He is an expert laparoscopic & Robotic surgeon. He has performed more than 700 major cancer operations (including prostate, bladder and kidney).
Prof Madaan has a regional & national profile. He is an expert advisor to NICE centre for Guidelines and was involved in writing latest prostate cancer guidelines published in 2019. He is chairman of Urology tumour group at Kent & medway cancer alliance. He is also lead for Urology cancer research in KSS (Kent, Surry & Sussex). He has interest in teaching and is actively involved in the laparoscopic training. He is a visiting professor with Canterbury Christchurch University.
Prof Madaan uses innovative techniques like targeted prostate biopsy (fusion biopsy) for better detection of prostate cancer & blue light cystoscopy for bladder cancers. He also started various other new services at DVH including hyperthermia MMC for the treatment of bladder cancer and supported self-management for patients with prostate cancer. He is winner of ‘DVH hospital innovation and improvement award 2015’ for his innovation and introduction of new services.
Areas of interest
Prostate disease including BPH and prostate cancer - Robotic prostatectomy; Bladder problems including Bladder cancer; kidney stones and Kidney (renal) cancer - laparoscopic nephrectomy; Urological oncology; Laparoscopic procedures ('keyhole surgery') e.g. laparoscopic pyeloplasty, laparoscopic varicocele ligation etc; LUTS; incontinence; impotence; testis related problems; Most general urology conditions
- Christina Smith
- Darent Valley Hospital Darenth Wood Road DARTFORD DA2 8DA
- 01322 428612
- 07912 418556
Current NHS consultant posts held
Prof Madaan's NHS base is at Darent Valley Hospital, Dartford
He also does a weekly operating list at Medway Maritime Hospital where he undertakes complex major robotic & laparoscopic cancer operations
Prof Madaan’s commitment to evidence-based medicine is obvious in his passion for research. He did a research in prostate cancer at Imperial College and was awarded PhD. He has been involved in both clinical and basic science research. He has published more than 70 papers.
He is research lead for urology department and is a principal investigator for fifteen urology clinical research trials with excellent recruitment record.
He is CRN subspecialty lead for Urology cancer research in Kent, Surrey & Sussex.
He is honorary Visiting Professor of Urology at Canterbury Christchurch University
Active role in hospital fund raising and charity events. He has helped raise large amount of funds and used these to introduce many new services in the region.
Received various awards - Arthur and Violet Pane Memorial Research Scholarship, Ian Sunter Charitable Trust Research Fellowship, British Oncology Association Travel Award, Pfizer Academic Travel Award 2000, Royal College of Physicians and Surgeons of Glasgow Travel award and EAU scholarship;
‘the team of the year award’ in the DVH hospital awards 2010; winner of ‘DVH hospital innovation and improvement award 2015’.
National Bronze Clinical Excellence Award
(Additional) Languages spoken
- Hindi - Native or bilingual
- Panjabi, Punjabi - Fluent
- Urdu - Fluent
Prof Madaan has published widely with over 60 peer-reviewed publications. In addition he has presented in various regional, national & international meetings and won awards.Last few publications listed below
1. Jayawardhana Tamani, Alsayed Hossam, Goel Amit, Madaan Sanjeev. Non-Muscle Invasive Clear Cell Carcinoma of the Urinary Bladder – Is Cystectomy Necessary? Accepted for publication in BMJ case reports Feb 2019. Doi: 10.1136/bcr-2018-226928
2. Kannappa Lava Krishna, Hureibi Khalid, Abbaraju Jaisimha, Madaan Sanjeev, Sriprasad Seshadri. Systematic review of Surgery of Solitary metastasis Post Nephrectomy and its survival. International Journal of Surgery and Surgical Sciences Vol 6, No 2 (2018)
3. van Valenberg FJP, Kajtazovic A, Canepa G, Lüdecke G, Kilb JI, Aben KKH, Nativ O, Madaan S, Ayres B, Issa R, Witjes JA. Intravesical Radiofrequency-Induced Chemohyperthermia for Carcinoma in Situ of the Urinary Bladder: A Retrospective Multicentre Study. Bladder Cancer. 2018 Oct 29;4(4):365-376. doi: 10.3233/BLC-180187.
4. Kelly JD1, Tan WS2, Porta N3, Mostafid H4, Huddart R5, Protheroe A6, Bogle R7, Blazeby J8, Palmer A9, Cresswell J10, Johnson M11, Brough R12, MadaanS13, Andrews S14, Cruickshank C3, Burnett S3, Maynard L3, Hall E3; BOXIT Investigators. BOXIT-A Randomised Phase III Placebo-controlled Trial Evaluating the Addition of Celecoxib to Standard Treatment of Transitional Cell Carcinoma of the Bladder (CRUK/07/004). Eur Urol. 2018 Sep 29. pii: S0302-2838(18)30683-3. doi: 10.1016/j.eururo.2018.09.020. [Epub ahead of print]
5. Tan WS, Panchal A, Buckley L, Devall AJ, Loubière LS, Pope AM, Feneley MR, Cresswell J, Issa R, Mostafid H, Madaan S, Bhatt R, McGrath J, Sangar V, Griffiths TRL, Page T, Hodgson D, Datta SN, Billingham LJ, Kelly JD. Radiofrequency-induced Thermo-chemotherapy Effect Versus a Second Course of Bacillus Calmette-Guérin or Institutional Standard in Patients with Recurrence of Non-muscle-invasive Bladder Cancer Following Induction or Maintenance Bacillus Calmette-Guérin Therapy (HYMN): A Phase III, Open-label, Randomised Controlled Trial. Eur Urol. 2018 Sep 28. pii: S0302-2838(18)30655-9. doi: 10.1016/j.eururo.2018.09.005. [Epub ahead of print]
6. Hossam Alsayed, Sanjeev Madaan. Management of BCG failure in high-risk non-muscle invasive bladder cancer. Accepted as a source content for Interactive e-learning modules on BJUI Knowledge.
Courses offered to GPs
Mr Madaan regularly offer GP teachings and has presented following topics -
Outcomes (checked and approved by medical professional body)
Please click on this link if you would like to see information about this healthcare professional’s performance compared to their peers, as published by their medical professional body.http://www.baus.org.uk/patients/surgeons/829
re-admission rate 2%
Return to theatre rate <1%
Excellent continence following radical prostatectomy (97%)
- MBBS University of Delhi 1988
- MS (General Surgery): University of Delhi 1991
- FRCS Royal College of Physicians and Surgeons of Glasgow 1995
- PhD University of London 2003
- FRCS (Urol): Intercollegiate board in Urology 2006
- FEBU European Board of Urology 2008
- Diploma in minimal access surgery European Institute of Telesurgery, Strasbourg, France 2011
Reference number 4277910
Professional bodies (positions held - last 3 yrs)
- Specialty lead for urology cancer research Cancer Research Network for Kent, Surrey & Sussex 2019
- Specialist Member NICE Advisory Committee for prostate cancer 2019
- Cancer Lead Darent Valley Hospital 2019
- Expert Advisor NICE (National Institute for clinical Excellence) 2019
- Honorary Visiting Professor Canterbury & Christchurch University 2019
- Chairman Urology TSSG Kent & Medway 2019
Details of entry to specialist register
- Urology, 2007
Affiliations / memberships
• British Association of Urological Surgeons (BAUS)
• Royal College of Physicians and Surgeons of Glasgow - fellow
• British Medical Association (BMA)
• The Medical Defence Union (MDU)
• European Association of Urology (EAU)
• American Urology Association (AUA)
• Royal Society of Medicine (RSM)
• Urological Society of India (USI)
- BMI Blackheath Hospital
- 14:30 - 16:30
- 020 8318 7722
- BMI Chelsfield Park Hospital
- 08:30 - 10:30
- 01689 877855
- Spire Alexandra Hospital, ME5 9PG
- 11:30 - 13:30
- 01634 687166
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
In the event of an urgent query following treatment, Bupa members should use the following contact details
The patients will normally contact Mr Madaan directly via the hospital where they have been treated